Scaglione, G.L.; Lombardo, V.; Polano, M.; Scandurra, G.; Pettinato, A.; Giunta, C.; Iemmolo, R.; Scollo, P.; Capoluongo, E.D.
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment. Biomolecules 2025, 15, 745.
https://doi.org/10.3390/biom15050745
AMA Style
Scaglione GL, Lombardo V, Polano M, Scandurra G, Pettinato A, Giunta C, Iemmolo R, Scollo P, Capoluongo ED.
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment. Biomolecules. 2025; 15(5):745.
https://doi.org/10.3390/biom15050745
Chicago/Turabian Style
Scaglione, Giovanni Luca, Valentina Lombardo, Maurizio Polano, Giuseppa Scandurra, Angela Pettinato, Corrado Giunta, Rosario Iemmolo, Paolo Scollo, and Ettore D. Capoluongo.
2025. "Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment" Biomolecules 15, no. 5: 745.
https://doi.org/10.3390/biom15050745
APA Style
Scaglione, G. L., Lombardo, V., Polano, M., Scandurra, G., Pettinato, A., Giunta, C., Iemmolo, R., Scollo, P., & Capoluongo, E. D.
(2025). Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment. Biomolecules, 15(5), 745.
https://doi.org/10.3390/biom15050745